Please try another search
Genprex, Inc., a clinical-stage gene therapy company, focuses on developing gene-based therapies for patients with cancer and diabetes in the United States. The company’s lead product candidate is REQORSA (GPX-001), which is in preclinical trials to treat non-small cell lung cancer and small cell lung cancer; and GPX-002, which is in preclinical trials to treat type 1 and type 2 diabetes. Its product pipeline comprises Acclaim-1, which is in phase 2a clinical trial for the treatment of non-small cell lung cancer; Acclaim-2, which is in phase phase 1/2 clinical trial for the treatment of non-small cell lung cancer; and Acclaim-3, which is in phase 1/2 clinical trial for the treatment of small cell lung cancer. The company also develops ONC-001, REQORSA as a monotherapy, which is in phase 1 clinical trial to treat advance non-small cell lung cancer; and ONC-002, REQORSA with Tarceva, which is in phase 2 clinical trial to treat non-small cell lung cancer. Genprex, Inc. was incorporated in 2009 and is headquartered in Austin, Texas.
Name | Age | Since | Title |
---|---|---|---|
Jack A. Roth | - | - | Chairman of Scientific & Medical Advisory Board |
Brent M. Longnecker | 68 | 2020 | Independent Director |
Shu Kam Mok | 64 | - | Member of Scientific & Medical Advisory Board |
Pasi Antero Janne | - | - | Member of Scientific & Medical Advisory Board |
George K. Gittes | - | 2020 | Member of Scientific Advisory Board |
George Simon | - | - | Member of Scientific & Medical Advisory Board |
James E. Rothman | 73 | 2012 | Strategic Advisor to the Board of Directors |
John Rodney Varner | 67 | 2012 | Co-Founder, Chairman, President & CEO |
Jose Antonio Moreno Toscano | 51 | 2020 | Independent Director |
George E. Peoples | - | 2021 | Member of Clinical Advisory Board |
Michael Morse | - | 2021 | Member of Clinical Advisory Board |
William R. Wilson | 74 | 2020 | Independent Director |
Andrew B. Becker | - | 2021 | Member of Clinical Advisory Board |
Are you sure you want to block %USER_NAME%?
By doing so, you and %USER_NAME% will not be able to see any of each other's Investing.com's posts.
%USER_NAME% was successfully added to your Block List
Since you’ve just unblocked this person, you must wait 48 hours before renewing the block.
I feel that this comment is:
Thank You!
Your report has been sent to our moderators for review